Morning Overview on MSN
A new daily pill beat oral Ozempic for weight loss and blood sugar in a major diabetes trial
Eli Lilly’s once-daily oral pill orforglipron outperformed oral semaglutide in reducing blood sugar and body weight over 52 ...
A new study reveals optimal ADHD medication dosages to improve symptom management while minimizing side effects for youth and ...
A woman has saved £4,000 in a year on her food shopping after losing 11st on Mounjaro. Holly Barron, 22, gained eight stone ...
The study shows semaglutide's cardiovascular benefits are more closely tied to attained dose than weight loss, challenging ...
The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 39 new drug formulations under the ...
Morning Overview on MSN
A common diabetes drug is showing signs of slowing aging in people
Metformin, a drug prescribed to tens of millions of people with type 2 diabetes, is producing measurable shifts in molecular ...
New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Could aging be optional? According to renowned biological aging ...
Eli Lilly Canada announced today that Mounjaro® (tirzepatide), the first and only Health Canada-authorized once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 ...
A landmark global consensus involving 56 academic, clinical, and patient organisations across all world regions has proposed ...
Nashville welcomed SHM Converge 2026, and with it one of the conference’s most anticipated annual traditions: the Updates in Hospital Medicine session. Kencee Graves, MD, FHM, clinical professor of ...
Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results